Cargando…
Efficacy of the low dose apatinib plus deep hyperthermia as third-line or later treatment in HER-2 negative advanced gastric cancer
Aim: To observe the efficacy of the low dose apatinib plus deep hyperthermia as third-line or later treatment for patients with human epidermal growth factor receptor 2 (HER-2) negative advanced gastric cancer. Methods: 80 eligible patients with HER-2 negative advanced gastric cancer admitted to Jin...
Autores principales: | Han, Guohu, Sun, Changchun, Cui, Lihua, Huang, Yufeng, Yu, Lijiang, Liu, Shenzha, Tao, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350525/ https://www.ncbi.nlm.nih.gov/pubmed/37465317 http://dx.doi.org/10.3389/pore.2023.1611114 |
Ejemplares similares
-
Modulated Electro-Hyperthermia Supports the Effect of Gemcitabine Both in Sensitive and Resistant Pancreas Adenocarcinoma Cell Lines
por: Forika, Gertrud, et al.
Publicado: (2021) -
HMGB1 knockdown increases the radiosensitivity of esophageal squamous cell carcinoma by regulating the expression of molecules involved in DNA repair
por: Han, Guohu, et al.
Publicado: (2021) -
Apatinib combined with PD-1 antibody for third-line or later treatment of advanced gastric cancer
por: Cui, Qingli, et al.
Publicado: (2022) -
Canine environmental hyperthermia: a case series
por: STERN, Adam
Publicado: (2018) -
A combined approach for individualized lymphadenectomy in gastric cancer patients
por: Varga, Zsolt, et al.
Publicado: (2023)